# Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy

> **NCT01488279** · NA · COMPLETED · sponsor: **University of Vermont** · enrollment: 10 (actual)

## Conditions studied

- Pre-diabetes
- Impaired Fasting Glucose
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Dexamethasone 2.5 mg and Sitagliptin 100 mg
- **DRUG:** Dexamethasone 2.5 mg and placebo tablet

## Key facts

- **NCT ID:** NCT01488279
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-07
- **Final completion:** 2015-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01488279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01488279, "Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01488279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*